MedPath

Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg

Not Applicable
Active, not recruiting
Conditions
Skin Tumor
Interventions
Device: Negative pressure device
Procedure: Conventional care
Registration Number
NCT05451680
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

This randomized controlled non-sponsored trial on 60 patients evaluates if a portable negative-pressure device improves graft-take and decrease the risk of surgical complications for skin-cancer surgeries below the knee.

Detailed Description

Annually, 12 000 skin cancers are diagnosed in Finland. This randomized controlled non-sponsored trial evaluate if a portable negative-pressure device improves graft-take and decrease the risk of surgical complications. 60 patients over 18 years of age are included and randomly assigned to either the negative pressure-treatment group or the conventional treatment group. At the control appointment one-week postsurgery, graft take is documented as a primary outcome and any complications (necrosis, infection, hematoma/seroma) and adverse events (pain, skin reactions) as secondary outcomes. Adverse events are evaluated by a phone call 3 weeks postsurgery and based on medical records 3 months postsurgery.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • from referrals received by the Unit, or from patients undergoing follow-up who have skin cancer (basal cell carcinoma, squamous cell carcinoma or melanoma) or suspected skin cancer below the knee
Exclusion Criteria
  • Toe lesion, bleeding disorder, severe dementia, critical peripheralischemia, or skin disease that is expected to impair wound healing, such as pyoderma gangrenosum

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Negative-pressure treatmentNegative pressure deviceA negative pressure wound dressing is placed over the skin graft. Patients are started on compression therapy after surgery, unless there are contraindications, and standard oral and written postoperative immobilization and other treatment instructions are given.
Conventional treatmentConventional careA conventional antimicrobial wound dressing is placed on top of the graft. Patients are started on compression therapy after surgery, unless there are contraindications, and standard oral and written postoperative immobilization and other treatment instructions are given.
Primary Outcome Measures
NameTimeMethod
Graft take3 months

good, partial or poor graft take (%)

Secondary Outcome Measures
NameTimeMethod
Adverse events3 months

Necrosis, infection, hematoma/seroma (%)

Trial Locations

Locations (1)

HUS Iho- ja allergiasairaala

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath